dansylarginine n-(3-ethyl-1,5-pentanediyl)amide has been researched along with 1,2-oleoylphosphatidylcholine in 1 studies
Studies (dansylarginine n-(3-ethyl-1,5-pentanediyl)amide) | Trials (dansylarginine n-(3-ethyl-1,5-pentanediyl)amide) | Recent Studies (post-2010) (dansylarginine n-(3-ethyl-1,5-pentanediyl)amide) | Studies (1,2-oleoylphosphatidylcholine) | Trials (1,2-oleoylphosphatidylcholine) | Recent Studies (post-2010) (1,2-oleoylphosphatidylcholine) |
---|---|---|---|---|---|
32 | 0 | 0 | 2,016 | 0 | 822 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cawthern, KM; Hockin, MF; Kalafatis, M; Mann, KG | 1 |
1 other study(ies) available for dansylarginine n-(3-ethyl-1,5-pentanediyl)amide and 1,2-oleoylphosphatidylcholine
Article | Year |
---|---|
A model describing the inactivation of factor Va by APC: bond cleavage, fragment dissociation, and product inhibition.
Topics: Animals; Arginine; Cattle; Dansyl Compounds; Factor Va; Humans; Hydrolysis; Kinetics; Light; Liposomes; Models, Chemical; Peptide Fragments; Phosphatidylcholines; Phosphatidylserines; Protein C; Prothrombin; Scattering, Radiation | 1999 |